Prenetics Announces Participation in December Investor Conferences

Core Insights - Prenetics Global Limited, a leading health sciences company, will participate in two upcoming investor conferences in December 2024 [1][2][3] Group 1: Upcoming Conferences - The iAccess Alpha Virtual Best Ideas Winter Conference 2024 will take place on December 10-11, 2024, with a presentation by CEO Danny Yeung on December 10 at 10:00am ET [2] - One-on-one investor meetings will be held on December 11, 2024, featuring CEO Danny Yeung, CFO Stephen Lo, and President of Prenetics Americas David Vanderveen [2] - The 13th Annual ROTH Deer Valley Event will occur from December 11-13, 2024, in Park City, UT, where David Vanderveen will host one-on-one investor meetings [3] Group 2: Company Overview - Prenetics is dedicated to advancing consumer and clinical health, with initiatives including the IM8 health and wellness brand and Europa, a major sports distribution company in the USA [5] - The clinical division includes Insighta, a $200 million venture focused on multi-cancer early detection technologies, and ACT Genomics, which has received FDA clearance for comprehensive genomic profiling of solid tumors [5] - CircleDNA offers comprehensive DNA tests using next-generation sequencing (NGS), enhancing Prenetics' global impact on health [5]